{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:18:32Z","timestamp":1792045112035,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:00:00Z","timestamp":1413417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00774-014-0618-2","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T03:10:35Z","timestamp":1413342635000},"page":"560-568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24\u00a0months of age"],"prefix":"10.1007","volume":"33","author":[{"given":"Kirsten","family":"Kusumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Ayoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasigarn A.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Ingraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Mahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,16]]},"reference":[{"key":"618_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000110463","volume":"68","author":"FH Glorieux","year":"2007","unstructured":"Glorieux FH (2007) Treatment of osteogenesis imperfecta: who, why, what? Horm Res 68:8\u201311","journal-title":"Horm Res"},{"key":"618_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.berh.2007.12.012","volume":"22","author":"FH Glorieux","year":"2008","unstructured":"Glorieux FH (2008) Osteogenesis imperfecta. Best Pract Res Clin Rheumatol 22:85\u2013100","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"618_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101\u2013116","journal-title":"J Med Genet"},{"key":"618_CR4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.bone.2004.07.003","volume":"35","author":"LA DiMeglio","year":"2004","unstructured":"DiMeglio LA, Ford L, McClintock C, Peacock M (2004) Intravenous pamidronate treatment of children under 36\u00a0months of age with osteogenesis imperfecta. Bone 35:1038\u20131045","journal-title":"Bone"},{"key":"618_CR5","first-page":"1846","volume":"85","author":"H Plotkin","year":"2000","unstructured":"Plotkin H, Rauch F, Bishop NJ, Montpetit K, Ruck-Gibis J, Travers R, Glorieux FH (2000) Pamidronate treatment of severe osteogenesis imperfecta in children under 3\u00a0years of age. J Clin Endocrinol Metab 85:1846\u20131850","journal-title":"J Clin Endocrinol Metab"},{"key":"618_CR6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1442-200X.2008.02649.x","volume":"51","author":"K Hasegawa","year":"2009","unstructured":"Hasegawa K, Inoue M, Seino Y, Morishima T, Tanaka H (2009) Growth of infants with osteogenesis imperfecta treated with bisphosphonate. Pediatrics international: Off J Japan Pediatric Soc 51:54\u201358","journal-title":"Pediatrics international: Off J Japan Pediatric Soc"},{"key":"618_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S8756-3282(01)00619-6","volume":"30","author":"DB Burr","year":"2002","unstructured":"Burr DB (2002) Targeted and nontargeted remodeling. Bone 30:2\u20134","journal-title":"Bone"},{"key":"618_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/8756-3282(95)00439-4","volume":"18","author":"VT Lepola","year":"1996","unstructured":"Lepola VT, Hannuniemi R, Kippo K, Lauren L, Jalovaara P, Vaananen HK (1996) Long-term effects of clodronate on growing rat bone. Bone 18:191\u2013196","journal-title":"Bone"},{"key":"618_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"key":"618_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1592\/phco.24.2.195.33143","volume":"24","author":"RE Robinson","year":"2004","unstructured":"Robinson RE, Nahata MC, Hayes JR, Batisky DL, Bates CM, Mahan JD (2004) Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents. Pharmacotherapy 24:195\u2013197","journal-title":"Pharmacotherapy"},{"key":"618_CR11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ajcn\/32.3.607","volume":"32","author":"PV Hamill","year":"1979","unstructured":"Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM (1979) Physical growth: national Center for Health Statistics percentiles. Am J Clin Nutr 32:607\u2013629","journal-title":"Am J Clin Nutr"},{"key":"618_CR12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339:947\u2013952","journal-title":"N Engl J Med"},{"key":"618_CR13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","volume":"86","author":"E Astrom","year":"2002","unstructured":"Astrom E, Soderhall S (2002) Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 86:356\u2013364","journal-title":"Arch Dis Child"},{"key":"618_CR14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","volume":"110","author":"F Rauch","year":"2002","unstructured":"Rauch F, Travers R, Plotkin H, Glorieux FH (2002) The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Investig 110:1293\u20131299","journal-title":"J Clin Investig"},{"key":"618_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000351374","volume":"79","author":"MB Alcausin","year":"2013","unstructured":"Alcausin MB, Briody J, Pacey V, Ault J, McQuade M, Bridge C, Engelbert RH, Sillence DO, Munns CF (2013) Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of age. Horm Res Paediatr 79:333\u2013340","journal-title":"Horm Res Paediatr"},{"key":"618_CR16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","volume":"40","author":"F Rauch","year":"2007","unstructured":"Rauch F, Cornibert S, Cheung M, Glorieux FH (2007) Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta. Bone 40:821\u2013827","journal-title":"Bone"},{"key":"618_CR17","unstructured":"(2006) WHO Child Growth Standards based on length\/height, weight and age. Acta Paediatr Suppl 450:76\u201385"},{"key":"618_CR18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/BPO.0b013e318173a923","volume":"28","author":"S Poyrazoglu","year":"2008","unstructured":"Poyrazoglu S, Gunoz H, Darendeliler F, Bas F, Tutunculer F, Eryilmaz SK, Bundak R, Saka N (2008) Successful results of pamidronate treatment in children with osteogenesis imperfecta with emphasis on the interpretation of bone mineral density for local standards. J Pediatr Orthop 28:483\u2013487","journal-title":"J Pediatr Orthop"},{"key":"618_CR19","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","volume":"111","author":"L Zeitlin","year":"2003","unstructured":"Zeitlin L, Rauch F, Plotkin H, Glorieux FH (2003) Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 111:1030\u20131036","journal-title":"Pediatrics"},{"key":"618_CR20","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1210\/endo.143.5.8807","volume":"143","author":"I Kalajzic","year":"2002","unstructured":"Kalajzic I, Terzic J, Rumboldt Z, Mack K, Naprta A, Ledgard F, Gronowicz G, Clark SH, Rowe DW (2002) Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology 143:1594\u20131601","journal-title":"Endocrinology"},{"key":"618_CR21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bone.2004.03.008","volume":"35","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Mier RJ, Glorieux FH (2004) Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta. Bone 35:231\u2013234","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-014-0618-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-014-0618-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-014-0618-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T05:54:22Z","timestamp":1565934862000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-014-0618-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,16]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1007\/s00774-014-0618-2","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,16]]}}}